Department of Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
J Hosp Infect. 2013 Nov;85(3):196-205. doi: 10.1016/j.jhin.2013.07.009. Epub 2013 Aug 31.
Information regarding bloodstream infections (BSIs) in patients with kidney diseases is scarce and mainly derived from selected groups of patients.
To assess the characteristics of BSI in an unselected population of patients with kidney disease, including renal transplant recipients and patients with chronic kidney failure who were receiving or not receiving dialysis.
A retrospective cohort study of all patients who presented with BSI in the nephrology department of a large teaching hospital. Clinical records were reviewed according to a pre-established protocol. Standard definitions were used.
In all, 155 episodes of BSI were recorded in 108 patients. The incidence of BSI was 77.3 episodes per 1000 admissions, and 4.5 episodes per 100 patient-years. Haemodialysis patients had the highest incidence of BSI. The distribution of micro-organisms was as follows: Gram-negative, 52.3%; Gram-positive, 46.5%; fungi, 1.2%. Escherichia coli was the most frequently isolated micro-organism (27%). The BSI was classed as bacteraemia of unknown source (29.7%), urinary tract infection (23.2%), vascular access infection (17.4%), and other (29.7%). Eighteen patients (11.6%) developed septic shock or multi-organ failure, and the same proportion had persistent bacteraemia. The crude mortality rate was 14.6%. The risk factors for mortality were high Charlson index, persistent bacteraemia, and absence of fever.
Nephrology patients have a high incidence of BSI, particularly patients undergoing haemodialysis. The predominant micro-organisms causing BSI episodes were Gram-negative bacilli. Patients with kidney disease have high BSI-related morbidity and mortality. Risk factors for mortality were high Charlson comorbidity index and persistent BSI. The presence of fever during the BSI episodes was found to be a protective factor.
关于肾脏病患者血流感染(BSI)的信息很少,主要来自于选定的患者群体。
评估未选择的肾脏病患者中 BSI 的特征,包括肾移植受者和接受或未接受透析的慢性肾衰竭患者。
这是一项对在一家大型教学医院肾病科就诊的所有 BSI 患者的回顾性队列研究。根据预先制定的方案审查临床记录。使用标准定义。
共记录了 108 例患者中的 155 例 BSI 发作。BSI 的发生率为每 1000 例住院患者 77.3 例,每 100 例患者年 4.5 例。血液透析患者的 BSI 发生率最高。微生物分布如下:革兰氏阴性菌,52.3%;革兰氏阳性菌,46.5%;真菌,1.2%。大肠杆菌是最常分离到的微生物(27%)。BSI 被归类为不明来源的菌血症(29.7%)、尿路感染(23.2%)、血管通路感染(17.4%)和其他(29.7%)。18 例(11.6%)患者发生感染性休克或多器官功能衰竭,相同比例的患者存在持续性菌血症。总的死亡率为 14.6%。死亡的危险因素是高 Charlson 指数、持续性菌血症和无发热。
肾病患者的 BSI 发生率较高,尤其是血液透析患者。导致 BSI 发作的主要微生物是革兰氏阴性杆菌。患有肾脏疾病的患者 BSI 相关发病率和死亡率较高。死亡的危险因素是高 Charlson 合并症指数和持续性菌血症。BSI 发作期间存在发热被认为是一个保护因素。